Unibios Holdings S.A. (BIOSK.AT)
EUR 1.53
(2.0%)
EUR 1.53
(2.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.45 Million EUR | 23.76% |
| 2022 | 1.78 Million EUR | 41.86% |
| 2021 | 1.22 Million EUR | 42.0% |
| 2020 | 840.35 Thousand EUR | -33.88% |
| 2019 | 1.15 Million EUR | 166.62% |
| 2018 | 444.12 Thousand EUR | -15.64% |
| 2017 | 579.58 Thousand EUR | 798.3% |
| 2016 | -83 Thousand EUR | -112.48% |
| 2015 | 665 Thousand EUR | -39.44% |
| 2014 | 1.09 Million EUR | -5.99% |
| 2013 | 1.13 Million EUR | 252.17% |
| 2012 | -931 Thousand EUR | 10.77% |
| 2011 | -489.09 Thousand EUR | 41.83% |
| 2010 | -1.47 Million EUR | -1126.83% |
| 2009 | 144.01 Thousand EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 388.81 Thousand EUR | 0.0% |
| 2024 Q1 | 388.81 Thousand EUR | -86.37% |
| 2023 Q2 | 598.83 Thousand EUR | 120.22% |
| 2023 Q3 | 695.67 Thousand EUR | 16.17% |
| 2023 FY | - EUR | 23.76% |
| 2023 Q4 | 695.67 Thousand EUR | 0.0% |
| 2023 Q1 | 271.92 Thousand EUR | -80.33% |
| 2022 FY | - EUR | 41.86% |
| 2022 Q1 | 144.58 Thousand EUR | -82.38% |
| 2022 Q2 | 320.69 Thousand EUR | 121.8% |
| 2022 Q3 | 679.14 Thousand EUR | 111.77% |
| 2022 Q4 | 1.38 Million EUR | 103.6% |
| 2021 Q3 | 324.87 Thousand EUR | 59.72% |
| 2021 Q2 | 203.4 Thousand EUR | 19.19% |
| 2021 FY | - EUR | 42.0% |
| 2021 Q1 | 170.65 Thousand EUR | -75.44% |
| 2021 Q4 | 820.4 Thousand EUR | 152.53% |
| 2020 Q3 | 366 Thousand EUR | 996.64% |
| 2020 FY | - EUR | -33.88% |
| 2020 Q4 | 694.84 Thousand EUR | 89.84% |
| 2020 Q1 | -24.21 Thousand EUR | -104.05% |
| 2020 Q2 | -40.82 Thousand EUR | -68.6% |
| 2019 Q1 | 221.1 Thousand EUR | 728.91% |
| 2019 Q3 | 293.55 Thousand EUR | -50.8% |
| 2019 Q2 | 596.59 Thousand EUR | 169.82% |
| 2019 Q4 | 598.07 Thousand EUR | 103.74% |
| 2019 FY | - EUR | 166.62% |
| 2018 Q1 | 215.42 Thousand EUR | 491.27% |
| 2018 FY | - EUR | -15.64% |
| 2018 Q4 | -35.15 Thousand EUR | 0.0% |
| 2018 Q3 | -35.15 Thousand EUR | -116.32% |
| 2018 Q2 | 215.42 Thousand EUR | -0.0% |
| 2017 Q1 | 63.17 Thousand EUR | 122.29% |
| 2017 Q2 | 63.17 Thousand EUR | 0.0% |
| 2017 Q4 | 36.43 Thousand EUR | 0.0% |
| 2017 Q3 | 36.43 Thousand EUR | -42.32% |
| 2017 FY | - EUR | 798.3% |
| 2016 Q2 | 164 Thousand EUR | 0.0% |
| 2016 FY | - EUR | -112.48% |
| 2016 Q4 | -283.43 Thousand EUR | 0.0% |
| 2016 Q1 | 164 Thousand EUR | -72.71% |
| 2016 Q3 | -283.43 Thousand EUR | -272.83% |
| 2015 FY | - EUR | -39.44% |
| 2015 Q1 | -241 Thousand EUR | -150.63% |
| 2015 Q3 | 52 Thousand EUR | -79.37% |
| 2015 Q4 | 601 Thousand EUR | 1055.77% |
| 2015 Q2 | 252 Thousand EUR | 204.56% |
| 2014 Q3 | 334 Thousand EUR | -8.24% |
| 2014 Q1 | -76 Thousand EUR | -115.51% |
| 2014 FY | - EUR | -5.99% |
| 2014 Q4 | 476 Thousand EUR | 42.51% |
| 2014 Q2 | 364 Thousand EUR | 578.95% |
| 2013 Q1 | -261 Thousand EUR | -269.87% |
| 2013 Q3 | 432.12 Thousand EUR | -14.72% |
| 2013 Q4 | 490 Thousand EUR | 13.39% |
| 2013 Q2 | 506.74 Thousand EUR | 294.15% |
| 2013 FY | - EUR | 252.17% |
| 2012 Q4 | -70.56 Thousand EUR | 30.76% |
| 2012 Q2 | -336.97 Thousand EUR | 0.0% |
| 2012 Q3 | -101.91 Thousand EUR | 69.76% |
| 2012 FY | - EUR | 10.77% |
| 2011 FY | - EUR | 41.83% |
| 2010 FY | - EUR | -1126.83% |
| 2009 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|